IRADIMED CORP — Director's Dealing 2023

Nov 13, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IRADIMED CORP (IRMD)
CIK: 0001325618
Period of Report: 2023-11-10

Reporting Person: VUOTO ANTHONY (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-11-10	Common Stock	S	818	$39.9079	Disposed	16375	Direct
2023-11-13	Common Stock	S	2237	$39.7504	Disposed	14138	Direct

Footnotes

F1: This transaction was executed in multiple trades at prices ranging from $39.84 to $39.95. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F2: This transaction was executed in multiple trades at prices ranging from $39.75 to $39.76. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.